(PG) Procter & Gamble - Overview

Sector: Consumer Defensive | Industry: Household & Personal Products | Exchange: NYSE (USA) | Market Cap: 339.136m USD | Total Return: -8.8% in 12m

Personal Care, Home Care, Health Products, Baby Care
Total Rating 54
Safety 87
Buy Signal -0.28
Household & Personal Products
Industry Rotation: -6.6
Market Cap: 339B
Avg Turnover: 1.22B USD
ATR: 1.87%
Peers RS (IBD): 31.8
Risk 5d forecast
Volatility19.2%
Rel. Tail Risk0.37%
Reward TTM
Sharpe Ratio-0.62
Alpha-6.69
Character TTM
Beta-0.099
Beta Downside-0.369
Drawdowns 3y
Max DD21.14%
CAGR/Max DD0.06
EPS (Earnings per Share) EPS (Earnings per Share) of PG over the last years for every Quarter: "2021-03": 1.26, "2021-06": 1.13, "2021-09": 1.61, "2021-12": 1.66, "2022-03": 1.33, "2022-06": 1.21, "2022-09": 1.57, "2022-12": 1.59, "2023-03": 1.37, "2023-06": 1.37, "2023-09": 1.83, "2023-12": 1.84, "2024-03": 1.52, "2024-06": 1.4, "2024-09": 1.93, "2024-12": 1.88, "2025-03": 1.54, "2025-06": 1.48, "2025-09": 1.99, "2025-12": 1.88,
EPS CAGR: 9.67%
EPS Trend: 62.5%
Last SUE: 0.42
Qual. Beats: 0
Revenue Revenue of PG over the last years for every Quarter: 2021-03: 18109, 2021-06: 18946, 2021-09: 20338, 2021-12: 20953, 2022-03: 19381, 2022-06: 19515, 2022-09: 20612, 2022-12: 20773, 2023-03: 20068, 2023-06: 20553, 2023-09: 21871, 2023-12: 21441, 2024-03: 20195, 2024-06: 20532, 2024-09: 21737, 2024-12: 21882, 2025-03: 19776, 2025-06: 20889, 2025-09: 22386, 2025-12: 22208,
Rev. CAGR: 3.70%
Rev. Trend: 63.4%
Last SUE: -0.34
Qual. Beats: 0

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Description: PG Procter & Gamble

The Procter & Gamble Company (PG) is a global consumer packaged goods company. It operates across five segments: Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care. This business model relies on consistent demand for essential household items.

PGs product portfolio includes prominent brands such as Head & Shoulders, Old Spice, Olay, Gillette, Crest, Vicks, Tide, Cascade, Pampers, and Always. The company distributes its products through a diverse range of channels, including mass merchandisers, e-commerce, grocery stores, and pharmacies. The consumer staples sector is generally considered defensive due to stable demand regardless of economic conditions.

Further research can provide deeper insights into Procter & Gambles market position and financial health.

Headlines to Watch Out For
  • Global consumer spending trends impact sales across all segments
  • Raw material and transportation costs affect profit margins
  • Competition from private label brands erodes market share
  • Foreign currency fluctuations influence international revenue
  • Regulatory changes in product safety impact manufacturing costs
Piotroski VR‑10 (Strict) 6.5
Net Income: 16.47b TTM > 0 and > 6% of Revenue
FCF/TA: 0.12 > 0.02 and ΔFCF/TA -1.96 > 1.0
NWC/Revenue: -11.86% < 20% (prev -9.67%; Δ -2.19% < -1%)
CFO/TA 0.15 > 3% & CFO 19.07b > Net Income 16.47b
Net Debt (25.81b) to EBITDA (23.62b): 1.09 < 3
Current Ratio: 0.72 > 1.5 & < 3
Outstanding Shares: last quarter (2.42b) vs 12m ago -1.39% < -2%
Gross Margin: 50.68% > 18% (prev 0.51%; Δ 5.02k% > 0.5%)
Asset Turnover: 68.23% > 50% (prev 68.78%; Δ -0.55% > 0%)
Interest Coverage Ratio: 18.73 > 6 (EBITDA TTM 23.62b / Interest Expense TTM 846.0m)
Altman Z'' 5.55
A: -0.08 (Total Current Assets 26.59b - Total Current Liabilities 36.70b) / Total Assets 127.29b
B: 1.05 (Retained Earnings 133.98b / Total Assets 127.29b)
C: 0.13 (EBIT TTM 15.84b / Avg Total Assets 124.96b)
D: 1.70 (Book Value of Equity 125.88b / Total Liabilities 73.97b)
Altman-Z'' Score: 5.55 = AAA
Beneish M -3.04
DSRI: 1.00 (Receivables 6.28b/6.23b, Revenue 85.26b/84.35b)
GMI: 1.01 (GM 50.68% / 51.34%)
AQI: 0.98 (AQ_t 0.60 / AQ_t-1 0.61)
SGI: 1.01 (Revenue 85.26b / 84.35b)
TATA: -0.02 (NI 16.47b - CFO 19.07b) / TA 127.29b)
Beneish M-Score: -3.04 (Cap -4..+1) = AA
What is the price of PG shares? As of April 12, 2026, the stock is trading at USD 145.16 with a total of 9,584,140 shares traded.
Over the past week, the price has changed by +1.67%, over one month by -6.95%, over three months by +1.90% and over the past year by -8.80%.
Is PG a buy, sell or hold? Procter & Gamble has received a consensus analysts rating of 4.04. Therefore, it is recommended to buy PG.
  • StrongBuy: 11
  • Buy: 5
  • Hold: 8
  • Sell: 1
  • StrongSell: 0
What are the forecasts/targets for the PG price?
Analysts Target Price 166.8 14.9%
Procter & Gamble (PG) - Fundamental Data Overview as of 10 April 2026
P/E Trailing = 20.9091
P/E Forward = 19.4553
P/S = 3.9777
P/B = 6.3473
P/EG = 3.8928
Revenue TTM = 85.26b USD
EBIT TTM = 15.84b USD
EBITDA TTM = 23.62b USD
Long Term Debt = 25.58b USD (from longTermDebt, last quarter)
Short Term Debt = 11.06b USD (from shortTermDebt, last quarter)
Debt = 36.64b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 25.81b USD (from netDebt column, last quarter)
Enterprise Value = 364.95b USD (339.14b + Debt 36.64b - CCE 10.82b)
Interest Coverage Ratio = 18.73 (Ebit TTM 15.84b / Interest Expense TTM 846.0m)
EV/FCF = 24.58x (Enterprise Value 364.95b / FCF TTM 14.85b)
FCF Yield = 4.07% (FCF TTM 14.85b / Enterprise Value 364.95b)
FCF Margin = 17.42% (FCF TTM 14.85b / Revenue TTM 85.26b)
Net Margin = 19.31% (Net Income TTM 16.47b / Revenue TTM 85.26b)
Gross Margin = 50.68% ((Revenue TTM 85.26b - Cost of Revenue TTM 42.05b) / Revenue TTM)
Gross Margin QoQ = 51.22% (prev 51.37%)
Tobins Q-Ratio = 2.87 (Enterprise Value 364.95b / Total Assets 127.29b)
Interest Expense / Debt = 0.60% (Interest Expense 220.0m / Debt 36.64b)
Taxrate = 20.11% (1.09b / 5.42b)
NOPAT = 12.66b (EBIT 15.84b * (1 - 20.11%))
Current Ratio = 0.72 (Total Current Assets 26.59b / Total Current Liabilities 36.70b)
Debt / Equity = 0.69 (Debt 36.64b / totalStockholderEquity, last quarter 53.32b)
Debt / EBITDA = 1.09 (Net Debt 25.81b / EBITDA 23.62b)
Debt / FCF = 1.74 (Net Debt 25.81b / FCF TTM 14.85b)
Total Stockholder Equity = 52.72b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.18% (Net Income 16.47b / Total Assets 127.29b)
RoE = 31.23% (Net Income TTM 16.47b / Total Stockholder Equity 52.72b)
RoCE = 20.23% (EBIT 15.84b / Capital Employed (Equity 52.72b + L.T.Debt 25.58b))
RoIC = 14.52% (NOPAT 12.66b / Invested Capital 87.18b)
WACC = 5.14% (E(339.14b)/V(375.78b) * Re(5.64%) + D(36.64b)/V(375.78b) * Rd(0.60%) * (1-Tc(0.20)))
Discount Rate = 5.64% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: -100.0 | Cagr: -0.90%
[DCF] Terminal Value 86.63% ; FCFF base≈15.59b ; Y1≈16.07b ; Y5≈18.09b
[DCF] Fair Price = 218.3 (EV 535.86b - Net Debt 25.81b = Equity 510.05b / Shares 2.34b; r=6.0% [WACC]; 5y FCF grow 3.03% → 3.0% )
EPS Correlation: 62.48 | EPS CAGR: 9.67% | SUE: 0.42 | # QB: 0
Revenue Correlation: 63.40 | Revenue CAGR: 3.70% | SUE: -0.34 | # QB: 0
EPS current Year (2026-06-30): EPS=6.97 | Chg7d=-0.001 | Chg30d=-0.002 | Revisions Net=-1 | Growth EPS=+2.0% | Growth Revenue=+2.8%
EPS next Year (2027-06-30): EPS=7.31 | Chg7d=-0.021 | Chg30d=-0.026 | Revisions Net=-2 | Growth EPS=+4.9% | Growth Revenue=+2.8%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 3.1% (Discount Rate 7.9% - Earnings Yield 4.8%)
[Growth] Growth Spread = -0.4% (Analyst 2.8% - Implied 3.1%)
External Resources
Dataroma Stockcircle